Remifentanil does not increase urine output during oral surgery, contrary to its effect during other surgeries – a cohort study  by Ouchi, Kentaro & Sugiyama, Kazuna
ARTICLE IN PRESS+ModelBJANE-755; No. of Pages 5
Rev Bras Anestesiol. 2016;xxx(xx):xxx--xxx
REVISTA
BRASILEIRA  DE
ANESTESIOLOGIA Publicação  Oﬁcial  da  Sociedade  Brasileira  de  Anestesiologiawww.sba.com.br
SCIENTIFIC ARTICLE
Remifentanil  does  not  increase  urine  output  during
oral surgery,  contrary  to  its  effect  during  other
surgeries --  a  cohort  study
Kentaro Ouchi ∗, Kazuna Sugiyama
Department  of  Dental  Anesthesiology,  Field  of  Oral  and  Maxillofacial  Rehabilitation,  Kagoshima  University  Graduate  School  of
Medical and  Dental  Sciences,  Kagoshima,  Japan
Received  25  November  2015;  accepted  16  December  2015
KEYWORDS
Remifentanil;
Urine  output;
General  anesthesia
Abstract
Background:  An  increase  in  urine  output  by  remifentanil  injection  during  laparoscopic  proce-
dures and  surgeries  such  as  cardiac  and  gynecological  procedures,  due  to  suppression  of  the
stress response  to  surgery,  has  been  reported.  The  aim  of  our  prospective,  observational,  cohort
study was  to  assess  the  effect  of  remifentanil  analgesia  on  urine  output  during  dental  and  minor
oral surgery  by  comparing  intraoperative  urine  output  under  deﬁned  infusion  volumes  with  and
without the  use  of  remifentanil.
Methods:  Dental  patients  aged  16  years  or  older,  American  Society  of  Anesthesiologists  physical
status 1,  with  no  renal  diseases  or  abnormal  blood  values  of  serum  creatinine  and  BUN,  not  on
treatment  with  diuretic  drugs,  and  undergoing  minor  oro-maxillofacial  surgery  or  dental  treat-
ment under  inhalation  general  anesthesia  were  included  in  this  study.  Urethral  catheterization
was performed  after  anesthesia  induction,  and  urine  output  was  measured  every  30  min.  We
measured  urine  volume  (mL)  and  rate  of  urine  output  (mL/kg/h)  intraoperatively,  and  com-
pared these  parameters  between  patients  who  did  and  did  not  receive  remifentanil  during  the
intraoperative  period.
Results:  Eighty-seven  patients  were  categorized  into  the  remifentanil  group  (n  =  43)  or  remifen-
tanil non-use  group  (n  =  44).  Both  volume  of  urine  (mL)  and  rate  of  urine  output  (mL/kg/h)
were not  signiﬁcantly  different  between  the  two  groups  (remifentanil  group,  372.3  ±  273.5  mL,
1.8 ±  1.1  mL/kg/h;  remifentanil  non-use  group,  343.3  ±  283.3  mL,  1.9  ±  1.2  mL/kg/h;  p  =  0.63;
0.57).Please  cite  this  article  in  press  as:  Ouchi  K,  Sugiyama  K.  Remifentanil  does  not  increase  urine  output  dur-
ing  oral  surgery,  contrary  to  its  effect  during  other  surgeries  --  a  cohort  study.  Rev  Bras  Anestesiol.  2016.
http://dx.doi.org/10.1016/j.bjane.2015.12.004
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Conclusion:  Our  results  show  that  use  of  remifentanil  during  dental  and  minor  oral  surgeries
does not  increase  urine  output.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Remifentanil  não  aumenta  a  produc¸ão  de  urina  durante  cirurgia  oral,  contrariamente
ao  seu  efeito  durante  outras  cirurgias  --  estudo  de  coorte
Resumo
Justiﬁcativa:  Um  aumento  na  produc¸ão  de  urina  após  a  injec¸ão  de  remifentanil  durante  pro-
cedimentos  laparoscópicos  e  cirurgias  cardíacas  e  ginecológicas,  devido  à  supressão  da  resposta
ao estresse  da  cirurgia,  foi  relatado.  O  objetivo  de  nosso  estudo  prospectivo,  observacional  e  de
coorte foi  avaliar  o  efeito  da  analgesia  com  remifentanil  sobre  a  produc¸ão  de  urina  durante  cirur-
gia odontológica  e  oral  de  pequeno  porte,  comparando  a  produc¸ão  de  urina  no  intraoperatório
sob infusão  de  volumes  deﬁnidos,  com  e  sem  o  uso  de  remifentanil.
Métodos:  Pacientes  odontológicos  com  idades  ≥  16  anos,  estado  físico  ASA  I,  sem  doenc¸as  renais
ou valores  sanguíneos  anormais  de  creatinina  sérica  e  uréia,  sem  tratamento  com  diuréticos
e submetidos  à  cirurgia  bucomaxilofacial  de  pequeno  porte  ou  tratamento  odontológico  sob
anestesia  geral  inalatória  foram  incluídos  neste  estudo.  Cateterismo  uretral  foi  realizado  após
a induc¸ão  da  anestesia,  e  a  produc¸ão  de  urina  foi  medida  a  cada  30  min.  Medimos  o  volume  de
urina (mL)  e  a  taxa  de  produc¸ão  de  urina  (mL/kg/h)  no  intra-operatório  e  comparamos  esses
parâmetros  entre  os  pacientes  que  receberam  e  que  não-receberam  remifentanil  durante  o
período intraoperatório.
Resultados:  Oitenta  e  sete  pacientes  foram  designados  para  os  grupos  com  remifentanil  (n  =
43) ou  grupo  sem  remifentanil  (n  =  44).  O  volume  de  urina  (mL)  e  a  taxa  de  produc¸ão  de  urina
(mL/kg/h) não  foram  signiﬁcativamente  diferentes  entre  os  dois  grupos  (grupo  com  remifen-
tanil: 372,3  ±  273,5  mL,  1,8  ±  1,1  mL/k/h;  grupo  sem  remifentanil:  343,3  ±  283,3  mL,  1,9  ±
1,2 mL/kg/h;  p  =  0,63;  0,57).
Conclusão:  Nossos  resultados  mostram  que  o  uso  de  remifentanil  durante  as  cirurgias  odon-
tológicas  e  de  pequeno  porte  não  aumenta  a  produc¸ão  de  urina.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este
é um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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eportedly,  remifentanil  increases  urine  output  during
urgery,  probably  by  preventing  the  stress  response  to
urgery.1--5 Previous  studies  on  increases  in  urine  output  due
o  remifentanil  were  performed  during  laparoscopic,  car-
iac,  or  gynecological  surgeries,  but  its  effect  during  oral
nd  maxillofacial  treatment  has  not  been  reported.
The  aim  of  our  observational  study  was  to  compare  urine
utput  during  use  of  remifentanil  versus  non-use  of  remifen-
anil  in  patients  undergoing  minor  oral  surgery  or  dental
rocedures,  by  measuring  urine  output  under  deﬁned  infu-
ion  volumes  in  the  intraoperative  period.
ethodsPlease  cite  this  article  in  press  as:  Ouchi  K,  Sugiyama  
ing  oral  surgery,  contrary  to  its  effect  during  other  sur
http://dx.doi.org/10.1016/j.bjane.2015.12.004
ental  patients  aged  16  years  or  older,  undergoing  minor
ro-maxillofacial  surgery  and  dental  treatment  under
nhalational  general  anesthesia  at  the  Clinical  Department
t
w
U
df  Dental  Anesthesia,  Kagoshima  University  Medical  Dental
ospital  from  April  2011  to  March  2014  were  studied.  To  be
ncluded  in  the  study,  patients  had  to  be  American  Society
f  Anesthesiologists  physical  status  1.  Patients  with  known
enal  disease,  laboratory  data  indicative  of  abnormal  blood
alues  of  serum  creatinine  and  Blood  Urea  Nitrogen  (BUN),
nd  those  on  treatment  with  diuretic  drugs  were  excluded.
nformed  consent  for  oral  surgery  and  for  participation  in
his  study  under  general  anesthesia  was  obtained  from  each
atient.  The  institutional  review  board  of  Kagoshima  Uni-
ersity  Medical  Dental  Hospital  approved  the  study  protocol,
hich  was  conducted  in  accordance  with  the  Declaration  of
elsinki.
The  necessary  number  of  patients  required  for  the  study
as  determined  from  past  and  pilot  studies,  which  indi-
ated  that  at  least  41  patients  were  required  in  each  group
o  achieve  an  approximately  27%  increase  in  urine  output
3K.  Remifentanil  does  not  increase  urine  output  dur-
geries  --  a cohort  study.  Rev  Bras  Anestesiol.  2016.
ith  remifentanil,  at  an  ˛  risk  of  0.05  and  (1  −  ˇ)  of  0.95.
se  of  remifentanil  was  at  the  attending  anesthesiologist’s
iscretion.
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Table  1  Demographics  of  patients  in  the  remifentanil  use  and  non-use  groups.
Age  (years)  Height  (cm)  Weight  (kg)  Male/female
Remifentanil  group  43.5  ±  17.1  162.8  ±  8.9  60.4  ±  12.3  21/22
Nonuse group  41.8  ±  15.0  160.8  ±  10.4  57.7  ±  12.0  25/19
p-Value 0.61 0.35 0.32 0.52
Anesthesia  time  (min) Operation  time  (min) Infusion  volume  (mL) Blood  loss  (mL)
Remifentanil  group  209.1  ±  70.5  120.8  ±  64.3  981  ±  349  19.3  ±  18.0
 76.
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343.3  ±  283.3  mL,  1.9  ±  1.2  mL/kg/h;  p  =  0.63;  0.57,  respec-
tively)  (Table  3).
Table  2  Surgeries  performed  in  the  study  subjects.
Remifentanil
group
Nonuse  group
Tooth  extraction  15  19
Cyst extirpation  15  16
Plates  exclusion 4  2
Dental  treatment  2  2
Cleft lip  nasal  deformity 1  2
Dental  implant  1  0
Incisional  drainage  1  0
Sialolith  extirpation  1  0
Bone transplantation  0  1Nonuse group  184.5  ±  84.5  104.6  ±
p-Value 0.15  0.30
Anesthesia  protocol
According  to  current  recommendations,  patients  were
allowed  solid  foods  for  up  to  the  night  before  surgery,  and
clear  ﬂuids  for  up  to  2.5  h  before  general  anesthesia  induc-
tion.  An  intravenous  line  was  secured  for  administration
of  the  isotonic  ﬂuid  (140  mEq/L  sodium  with  1%  glucose;
Physio140,  Otsuka  Pharmaceutical,  Co.,  Ltd.,  Tokyo,  Japan).
Furthermore,  all  patients  continuously  underwent  non-
invasive  blood  pressure  and  electrocardiographic  monitoring
using  a  standard  automated  monitoring  device  (Marquette
Solar  8000M,  GE  Medical  Systems,  UK).  Anesthesia  was
induced  with  propofol  1.5  mg/kg  IV,  and  intubation  was  facil-
itated  with  the  IV  administration  of  rocuronium  0.9  mg/kg.
In  remifentanil-use  cases,  it  was  administered  at  the  rate  of
0.25  g/kg/min  during  anesthesia  induction.  Anesthesia  was
maintained  with  sevoﬂurane  (1.5%),  nitrous  oxide  (4  L/min)
and  oxygen  (2  L/min).  Remifentanil-use  cases  additionally
received  a  continuous  infusion  of  remifentanil  at  the  rate
of  0.05--0.15  g/kg/min.  Remifentanil  non-use  patients  did
not  receive  any  opioids.  Remifentanil-use  patients  did  not
receive  other  opioids.  Local  anesthesia  was  used  by  the  sur-
geons,  as  appropriate.  The  surgeons  were  unaware  of  the  use
or  non-use  of  remifentanil.  Rocuronium  was  administered
for  intubation,  with  no  additional  doses  being  administered
intraoperatively.  All  patients  received  4.5  mL/kg/h  of  the
crystalloid  ﬂuid  with  an  infusion  pump  from  the  time  of
securing  the  intravenous  line.  Urethral  catheterization  was
performed  after  anesthesia  induction  and  urine  output  was
measured  every  30  min  during  anesthesia.  If  patients  devel-
oped  hypotension  intraoperatively,  with  a  fall  in  systolic
BP  to  less  than  80  mm/Hg,  remifentanil  infusion  was  tem-
porarily  discontinued,  and  they  were  given  ephedrine.  These
patients  were  then  excluded  from  the  study.  All  anesthetics
were  stopped  at  the  end  of  surgery.
Measurement  of  parameters
We  measured  the  total  volume  of  urine  (mL)  and  volume
of  urine  per  kilogram  body  weight  per  unit  time  (mL/kg/h)
in  all  patients.  We  then  compared  these  values  between
remifentanil  use  and  non-use  groups.Please  cite  this  article  in  press  as:  Ouchi  K,  Sugiyama  
ing  oral  surgery,  contrary  to  its  effect  during  other  sur
http://dx.doi.org/10.1016/j.bjane.2015.12.004
Statistical  analyses
Continuous  demographic  and  laboratory  variables  were  com-
pared  using  the  unpaired  t-test,  and  the  Chi-square  test  was9  862  ±  351  26.6  ±  40.5
0.12  0.30
sed  for  categorical  variables.  JMP  software  (version  10,  SAS
nstitute  Inc.,  Japan)  was  used  for  statistical  analysis,  and
 <  0.05  was  regarded  as  being  statistically  signiﬁcant.  The
esults  are  presented  as  mean  ±  SD.
esults
ighty-seven  patients  were  included  in  this  study  and  were
ategorized  into  the  remifentanil  group  (n  =  43)  or  remifen-
anil  non-use  group  (n  =  44).  Table  1  shows  the  patients’
emographic  data  and  Table  2  lists  the  surgical  procedures
erformed.  Use  of  remifentanil  was  at  the  attending  anes-
hesiologist’s  discretion.  The  study  subjects  were  attended
o  by  one  of  the  four  anesthesiologists.  Anesthesiologists  A
nd  B  routinely  administer  remifentanil,  and  anesthesiolo-
ists  C  and  D  do  not  routinely  administer  remifentanil.  In
ases  in  which  it  was  used,  remifentanil  was  given  in  the
ose  range  of  0.05--0.15  g/kg/min.  Blood  pressure  during
he  intraoperative  period  decreased  by  more  than  15--25%
ompared  with  pre-anesthesia  values  in  both  groups.
Volume  of  urine  (mL)  and  volume  of  urine  per  kilogram
ody  weight  per  unit  time  (mL/kg/h)  were  not  signif-
cantly  different  between  the  two  groups  (remifentanil
roup,  372.3  ±  273.5  mL,  1.8  ±  1.1  mL/kg/h;  non-use  group,K.  Remifentanil  does  not  increase  urine  output  dur-
geries  --  a  cohort  study.  Rev  Bras  Anestesiol.  2016.
Osteoplasty  2  1
Leukoplakia  excision  1  1
Number  of  total  cases  43  44
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Table  3  Urine  output  with  and  without  the  use  of  remifen-
tanil during  dental/minor  oral  surgery.
Urine  output
(mL)
Weightily  hourly
urine  output
(mL/kg/h)
Remifentanil  group  372.3  ±  273.5  1.8  ±  1.1
Nonuse  group  343.3  ±  283.3  1.9  ±  1.2
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iscussion
he  purpose  of  this  study  was  to  evaluate  the  effect  of
emifentanil  on  urine  output  in  patients  undergoing  minor
ral  and  maxillofacial  surgery  under  general  anesthesia  with
itrous  oxide  and  sevoﬂurane.  The  authors  hypothesized
hat  remifentanil  would  increase  urine  output  during  oral
urgeries,  similar  to  that  during  laparoscopic  surgeries,  as
ell  as  cardiac  and  gynecological  procedures.  We  found,
owever,  that  remifentanil  does  not  increase  urine  out-
ut  during  dental  and  oral  surgery.  The  mechanism  of  the
reviously  reported  increase  in  urine  volume  by  remifen-
anil  is  believed  to  be  as  follows.  Adequate  analgesia  with
emifentanil  reduces  the  secretion  of  antidiuretic  hormone,
esulting  in  an  increase  in  urine  output.  One  of  the  pre-
ious  reports  states  that  the  increase  in  urine  volume
nduced  by  remifentanil  is  accompanied  by  a  decrease  in
atecholamine  secretion  and  a  highly  signiﬁcant  decrease
n  cortisol  excretion.1 In  other  reports,  although  the  lev-
ls  of  antidiuretic  hormone,  catecholamine  and  cortisol
ere  not  measured,  their  values  were  believed  to  have
ecreased.1,3--5 In  all  of  these  previous  reports,  the  sur-
eries  performed  were  those  in  which  local  anesthesia
lone  would  not  provide  adequate  analgesia.  In  laparoscopic
urgery  for  example,  because  a  wide  range  of  analgesia  is
equired  for  incision  of  the  peritoneum,  epidural  anesthesia
oes  not  provide  adequate  analgesia.1 Moreover,  in  laparo-
copic  surgery,  a  comparatively  higher  dose  of  remifentanil
s  required  to  decrease  the  catecholamine  secretion  induced
y  surgical  stimulation.6 Remifentanil  inﬂuences  the  release
f  stress  response  markers,  such  as  antidiuretic  hormone,
CTH,  cortisol,  noradrenaline  and  adrenaline.7,8 In  this
tudy,  in  both  the  groups,  irrespective  of  the  use  or  non-use
f  remifentanil,  anesthesia  was  maintained  with  sevoﬂurane
.5%,  nitrous  oxide  66.6%  and  oxygen  33.3%.  Consequently,
atients  received  1.51  MAC  of  inhalational  anesthetics,
ecause  1  MAC  of  sevoﬂurane  is  1.71%  and  that  of  nitrous
xide  is  105%.  Thus,  the  concentration  of  anesthetics  was
ufﬁcient  for  minor  surgery.  The  procedures  evaluated  in
his  study  included  minor  oral  surgeries,  such  as  tooth
xtraction  and  cyst  extirpation.  Minor  oral  surgery  is  usually
erformed  under  local  anesthesia  or  local  anesthesia  and
ntravenous  anesthesia/sedation  (non-use  of  opioids).  Even
left  lip  deformity  can  be  repaired  under  local  anesthesia.9
hus,  in  operations  in  this  study,  local  anesthesia  and  inhala-
ion  anesthetics  provided  adequate  analgesia  in  all  subjects,Please  cite  this  article  in  press  as:  Ouchi  K,  Sugiyama  
ing  oral  surgery,  contrary  to  its  effect  during  other  sur
http://dx.doi.org/10.1016/j.bjane.2015.12.004
ven  those  who  did  not  receive  remifentanil.  We  postu-
ate  that  the  absence  of  an  increase  in  urine  output  under
emifentanil  analgesia  during  minor  oral  and  dental  surgery,
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s  seen  in  this  study,  is  due  to  the  fact  that  in  these  pro-
edures,  anesthesia  without  remifentanil  provides  enough
nalgesia  that  the  stress  response,  and  hence,  stress  hor-
ones  release  is  blunted,  which  results  in  minimal  effect
f  remifentanil  on  these  hormones  and  hence,  on  urine
utput.
There  has  been  no  study  investigating  the  direct  effect
f  remifentanil  on  renal  function.  However,  previous  studies
n  the  preconditioning  effect  of  remifentanil  have  reported
hat  although  remifentanil  is  a  -receptor  agonist,  its  car-
ioprotective  effect  is  mediated  through    and    opioid
eceptors.  Reportedly,    receptor  action  may  increase  urine
utput,  because    agonists  have  been  reported  to  induce
iuresis  in  animal  studies.10,11 However,  urine  output  was  not
reater  in  the  remifentanil  group  in  this  study.  This  suggests
hat    receptor  action  is  not  responsible  for  the  increase  in
rine  output  induced  by  remifentanil.  Further  studies  are
eeded  to  elucidate  the  mechanism  of  the  diuresis  induced
y  remifentanil.
The  type  of  ﬂuid  administered  intraoperatively  may
ffect  urine  output.  It  is  reported  that  during  use  of
.9%  saline,  increased  afferent  arteriolar  resistance  reduces
enal  ﬂow  and  glomerular  ﬁltration  rate,  leading  to  reduced
rine  output.12 Consequently,  different  types  of  ﬂuids  may
ave  different  effects  on  urine  output.  Thus,  ﬂuid  infu-
ion  in  this  study  was  restricted  to  a  single  type  of  ﬂuid.
n  this  study,  ﬂuid  was  infused  at  the  rate  of  4.5  mL/kg/h.
or  a  60  kg  patient,  which  was  the  mean  weight  of  subjects
n  this  study,  this  amounted  to  270  mL/h.  If  ﬂuid  require-
ent  is  calculated  based  on  the  4-2-1  rule  (4  mL/kg/h
or  the  ﬁrst  10  kg  body  weight,  2  mL/kg/h  from  11  to
0  kg  and  1  mL/kg/h  for  every  kg  above  20  kg),  this  would
ave  amounted  to  100  mL/h  for  a  60  kg  patient.  Thus,  the
mount  of  maintenance  ﬂuid  administered  during  anes-
hesia  was  an  over  dose,  although  the  reason  for  this
ver-infusion  was  to  compensate  for  preoperative  dehydra-
ion  over  the  short  time  period  of  the  operation  (planned
or  0.5--2  h).
In  this  study,  use  of  remifentanil  was  at  the  attending
nesthesiologist’s  discretion.  While  the  decision  to  use  or
ot  use  remifentanil  differs  according  to  the  anesthesiol-
gist,  the  number  of  patients  in  the  two  groups  in  this
tudy  was  almost  identical.  Further,  since  the  rest  of  the
nesthesia  protocol,  other  than  use  or  non-use  of  remifen-
anil,  was  prescribed,  the  likelihood  of  operator  bias,  in
erms  of  the  attending  anesthesiologist,  in  this  study  is
inimal.
Not  all  minor  oral  surgical  procedures  are  performed
nder  general  anesthesia.  However,  even  if  the  surgery  can
e  adequately  performed  under  local  anesthesia  or  local
nesthesia  and  intravenous  anesthesia/sedation,  in  a  pre-
ious  study,  patients  who  underwent  surgery  under  general
nesthesia  reported  a  higher  satisfaction  rate  with  the  pro-
edure  as  compared  to  patients  who  had  surgery  under
ntravenous  sedation.13 Thus,  general  anesthesia  improves
atient  satisfaction.  Hence,  although  anesthesia  for  minor
ral  surgery  and  dental  treatment  does  not  necessarily  need
emifentanil,  if  given,  it  provides  adequate  analgesia  againstK.  Remifentanil  does  not  increase  urine  output  dur-
geries  --  a cohort  study.  Rev  Bras  Anestesiol.  2016.
he  stimulus  of  laryngoscopy  and  intubation.  Hence,  even
uring  anesthesia  for  minor  oral  surgery  and  dental  treat-
ent,  use  of  remifentanil  is  clearly  not  inappropriate.
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Remifentanil  does  not  increase  urine  output  during  oral  surg
Conclusions
In  conclusion,  our  results  suggest  that  use  of  remifentanil
does  not  increase  urine  output  during  general  anesthesia
with  nitrous  oxide  and  sevoﬂurane  for  dental  and  minor  oral
surgery.
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